Synthon
Edit

Synthon

http://www.synthon.com/
Last activity: 02.07.2019
Tags:DevelopmentHealthTechInformationLocalMarketMedTechOfficePageProductScience
Thank you for your interest in Synthon. We have set up this page to share news with you about Synthon. We would like to receive your thoughts on our updates, but content provided by anyone other than Synthon does not represent the opinions or positions of Synthon. In some cases we might need to remove your comment from our wall. • Please refrain from mentioning Synthon products or products from other companies. As we work in regulated industries and because of the unique legal situation in the health care space, we may not engage in discussions about sensitive topics or products, ours or those of other companies, on this page. • If your post describes possible side effects associated with a Synthon product, we may be required to get in touch with you for further information. Please contact us to report an adverse event related to Synthon products by sending an e-mail to drug.safety@synthon.com. • Comments or posts that are factually inaccurate or misleading, are spam, inappropriate, off-topic, abusive, use profanity or contain personal information, e.g. names of individuals, e-mail addresses or phone numbers, will be deleted. • Given the serious implications of unsolicited and unverified medical advice, any post containing medical advice will not be allowed on our page. We recommend that you consult your health care provider about personal health matters. There may be other circumstances that require us to remove a comment. Synthon reserves the right to delete any post at its sole discretion.
Likes
779
Mentions
4
Location: Netherlands, Gelderland, Nijmegen
Employees: 1001-5000
Phone: +31 24 372 7700
Founded date: 1991

Investors 2

Mentions in press and media 4

DateTitleDescriptionSource
02.07.2019BC Partners to Acquire Synthon International Holding B.V.London, 2nd July 2019 – Funds advised by BC Partners (“BC Partners”), a leading international privat...bcpartners...
03.03.2017Buy­out buzz cen­ters on a No­var­tis NASH deal for Gen­fit;...→ Gen­fit $GN­FT has be­come the tar­get of the lat­est round of M&A ru­mors. StreetInsid­er say...endpts.com...
19.05.2011Generic of UCB allergy med Xyzal gets preliminary FDA approv...Synthon said it believes it is the first to file an application with the FDA for a Xyzal generic. Be...medcitynew...
-Generic of UCB allergy med Xyzal gets preliminary FDA approv...Generic drug company Synthon Pharmaceuticals has received tentative U.S. Food and Drug Administratio...medcitynew...